Regulations.gov document
Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity…
Notice · FDA-2020-D-0987 · posted Mar 6, 2020
Key facts
| Document ID | FDA-2020-D-0987-0008 |
|---|---|
| Title | Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under the Clinical Laboratory Improvement Amendments Prior to Emergency Use Authorization for Coronavirus Disease-2019 During the Public Health Emergency; Immediately in Effect Guidance for Clinical Laboratories and Food and Drug Administration Staff; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2020-D-0987 |
| Posted | Mar 6, 2020 |
| Federal Register citation | 85 FR 13169 |
| FR document number | 2020-04630 |
| Comment period opens | Mar 6, 2020 |
| Effective date | Mar 6, 2020 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: